Rovi Pharmaceuticals Laboratories
Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.
-
Could a Four-Times-a-Year shot replace daily breast cancer pills?
Disease control Not yet recruitingThis study tests whether a new quarterly injection of letrozole delivers the same amount of drug into the bloodstream as the standard daily letrozole pill in postmenopausal women with hormone receptor-positive early breast cancer. About 120 women who have already completed at lea…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New injectable letrozole could offer same cancer control as pill
Disease control Not yet recruitingThis study tests if an injectable form of letrozole (Letrozole SIE) works as well as the standard pill (Femara) for controlling advanced breast cancer. Both groups also receive a targeted drug called ribociclib. About 300 postmenopausal women with HR-positive, HER2-negative breas…
Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated May 12, 2026 13:43 UTC